Baseline Trajectories of Drinking Moderate Acamprosate and Naltrexone Effects in the COMBINE Study

Alcoholism: Clinical and Experimental Research

Volumn 35, Issue 3, 2011, Pages 523-531

  Gueorguieva, Ralitza ^a   Wu, Ran ^b   Donovan, Dennis ^c   Rounsaville, Bruce J ^b   Couper, David ^d   Krystal, John H ^b,e   O'Malley, Stephanie S ^b  

^a YALE UNIVERSITY   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d University of North Carolina at Chapel Hill   (United States)

^e VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

Acamprosate; Clinical Trial; Latent Class; Naltrexone; Trajectory Based Analysis

Indexed keywords

ACAMPROSATE; NALTREXONE;

ABSTINENCE; ADULT; ALCOHOLISM; ARTICLE; BEHAVIOR THERAPY; DRINKING BEHAVIOR; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; ALCOHOL DETERRENTS; ALCOHOLISM; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; NALTREXONE; NARCOTIC ANTAGONISTS; TAURINE; TEMPERANCE;

EID: 79951878566     PISSN: 01456008     EISSN: 15300277     Source Type: Journal    
DOI: 10.1111/j.1530-0277.2010.01369.x     Document Type: Article

References (37)

1. Anton RF, Moak DH, Latham P (1995) The Obsessive Compulsive Drinking Scale: a self rated instrument for the quantification of thoughts about alcohol and drinking behavior. Alcohol Clin Exp Res 19:92-99.
2. Anton RF, O'Malley SS, Ciraulo DA, Cisler RA, Couper D, Donovan DM, Gastfriend DR, Hosking JD, Johnson BA, LoCastro JS, Longabaugh R, Mason BJ, Mattson ME, Miller WR, Pettinati HM, Randall CL, Swift R, Weiss RD, Williams LD, Zweben A; COMBINE Study Research Group (2006) Combined pharmacotherapies and behavioral interventions for alcohol dependence. The COMBINE study: a randomized controlled trial. JAMA 295:2003-2017.
3. Chick J, Lehert P, Landron F (2010) Does acamprosate improve reduction of drinking as well as aiding abstinence? J Psychopharmacology 17:397-402.
4. De Witte P, Pinto E, Ansseau M, Verbanck P (2003) Alcohol and withdrawal: from animal research to clinical issues. Neurosci Biobehav Rev 27:189-197.
5. Falk M, Mattson M, Fertig J, Ryan M, Litten R (2009) Efficacy of naltrexone in Combine trial using percentage of subjects with no heavy drinking days as treatment outcome measure. Alcohol Clin Exp Res 33:114A.
6. First MB, Spitzer RL, Gibbon M, Williams JBW (1997) Structured Clinical Interview for DSM-IV Axis I Disorders-Clinician Version (SCID-CV). American Psychiatric Press, Washington, DC.
7. Garbutt JC, Kranzler HR, O'Malley SS, Gastfriend DR, Pettinati HM, Silverman BJ, Loewy JW, Ehrich EW; Vivitrex Study Group (2005) Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial. JAMA 293:1617-1625.
8. Gueorguieva R, Wu R, Donnovan D, Rounsaville B, Couper D, Krystal J, O'Malley S (2010) Naltrexone and combined behavioral intervention effects on trajectories of drinking in the COMBINE study. Drug Alcohol Depen 107:221-229.
9. Hall SM, Havassy BE, Wasserman DA (1990) Commitment to abstinence and acute stress in relapse to alcohol, opiates, and nicotine. J Consult Clin Psychol 58:175-181.
10. Heilig M, Egli M (2006) Pharmacological treatment of alcohol dependence. Target symptoms and target mechanisms. Pharmacol Therapeut 111:855-876.
11. Jones B, Nagin DS, Roeder K (2001) A SAS procedure based on mixture models for estimating developmental trajectories. Sociol Methods Res 29:374-393.
12. Kampman KM, Pettinati HM, Lynch KG, Xie H, Dackis C, Oslin DW, Sparkman T, Sharkoski T, O'Brien CP (2009) Initiating acamprosate within detoxification in the treatment of alcohol dependence. Addict Behavior 34:581-586.
13. Kiefer F, Mann K (2006) Pharmacotherapy and behavioral intervention for alcohol dependence. JAMA 296:1727-1728.
14. Kranzler H, Gage G (2008) Acamprosate efficacy in alcohol-dependent patients: summary of results from three pivotal trials. American Journal of Addictions 717:70-76.
15. Lhuintre JP, Moore N, Tran G, Steru L, Langrenon S, Daoust M, Parot P, LaDure P, Libert C, Boismare F (1990) Acamprosate appears to decrease alcohol intake in weaned alcoholics. Alcohol Alcohol 25:613-622.
16. Mann K, Kiefer F, Spanagel R, Littleton J (2008) Acamprosate: recent findings and future research directions. Alcohol Clin Exp Res 32:1105-1110.
17. Mason BJ, Ownby RL (2000) Acamprosate for the treatment of alcohol dependence: a review of double-blind, placebo controlled trails. CNS Spectr 5:58-69.
18. Miller WR (1996) Form 90: A Structured Assessment Interview for Drinking and Related Behaviors. NIAAA Project MATCH Monograph Series. Government Printing Office, Washington.
19. Miller WR, Del Boca FK (1994) Measurement of drinking behavior using the Form 90 family of instruments. J Stud Alcohol Suppl 12:112-118.
20. Miller WR, Tonigan JS, Longabaugh R (1995) Drinker Inventory of Consequences (DrInC): An instrument for assessing adverse consequences of alcohol abuse. Test manual. National Institute on Alcohol Abuse and Alcoholism, Rockville, MD.
21. Muthén BO (19982004). Mplus Technical Appendices. Muthén & Muthén, Los Angeles, CA. Appendix 8.
22. Nagin DS (1999) Analyzing developmental trajectories: a semiparametric, group-based approach. Psychol Methods 4:139-157.
23. Nagin DS, Tremblay RE (2001) Analyzing developmental trajectories of distinct but related behaviors: a group-based method. Psychol Methods 6:18-34.
24. O'Malley SS, Garbutt JC, Gastfriend DR, Dong Q, Kranzler HR (2007) Efficacy of extended-release naltrexone in alcohol-dependent patients who are abstinent prior to treatment. J Clin Psychopharm 27:507-512.
25. O'Malley SS, Robin RW, Levenson AL, Greywolf I, Chance LE, Hodgkinson CA, Romano D, Robinson J, Meandzija B, Stillner V, Wu R, Goldman D (2008) Naltrexone alone and with sertraline for the treatment of alcohol dependence in Alaska Natives and Non-Natives residing in rural settings: a randomized controlled trial. Alcohol Clin Exp Res 32:1-13.
26. Pettinati HM, O'Brien CP, Rabinowitz AR, Wortman SP, Oslin DW, Kampman KM, Dackis CA (2006) The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking. J Clin Psychopharmacol 26:610-625.
27. Ray L, Krull JL, Leggio L (2010) The effects of Naltrexone among alcohol non-abstainers: results from the COMBINE Study. Frontiers of Psychiatry 10:3389.
28. Rosner S, Leucht S, Lehert P, Soyka M (2008) Acamprosate supports abstinence, naltrexone prevents excessive drinking: evidence from a meta-analysis with unreported outcomes. J Psychopharmacology 2008(22):11-23.
29. Sinclair JD (2001) Evidence about the use of naltrexone and four different ways of using it in the treatment of alcoholism. Alcohol Alcohol 36:2-10.
30. Skinner HA, Allen BA (1982) Alcohol dependence syndrome: measurement and validation. J Abnorm Psychol 91:199-209.
31. Sobell LC, Sobell MB (1992) Timeline Follow-back: a technique for assessing self-reported ethanol consumption, in Timeline Follow-back: A Technique for Assessing Self-Reported Ethanol Consumption in Measuring Alcohol Consumption: Psychosocial and Biological Methods (Allen J, Litten RZ eds), pp 41-72. Human Press, New Jersey.
32. Sobell LC, Sobell MB (1995) Alcohol consumption measures, in Assessing Alcohol Problems: A Guide for Clinician and Researchers (Allen JP, Columbus M eds), pp 55-73. National Institute on Alcohol Abuse and Alcoholism, Rockville, MD.
33. Stout RL (2000) What is a drinking episode? J Stud Alcohol 61(3), 455-461.
34. Sullivan JT, Sykora K, Schneiderman J, Naranjo CA, Sellers EM (1989) Assessment of alcohol withdrawal: the revised Clinical Institute Withdrawal Assessment for Alcohol scale (CIWA-AR). Br J Addict 84:1353-1357.
35. The COMBINE Study Research Group (2003) Testing combined pharmacotherapies and behavioral interventions in alcohol dependence: rationale and methods. Alcohol Clin Exp Res 27:1107-1122.
36. Tonigan JS, Miller WR, Brown JM (1997) The reliability of Form 90: an instrument for assessing alcohol treatment outcome. J Stud Alcohol 58:358-364.
37. Whitworth AB, Fischer F, Lesch OM, Nimmerrichter A, Oberbauer H, Platz T, Potgieter A, Walter H, Fleischhacker WW (1996) Comparison of acamproste and placebo in long-term treatment of alcohol dependence. Lancet 347:1438-1442.